You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 16, 2025

Drug Price Trends for SM SORE THROAT


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for SM SORE THROAT

Average Pharmacy Cost for SM SORE THROAT

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
SM SORE THROAT 1.4% SPRAY 49348-0991-36 0.01307 ML 2025-01-22
SM SORE THROAT 1.4% SPRAY 49348-0991-36 0.01313 ML 2024-12-18
SM SORE THROAT 1.4% SPRAY 49348-0991-36 0.01311 ML 2024-11-20
SM SORE THROAT 1.4% SPRAY 49348-0991-36 0.01307 ML 2024-10-23
SM SORE THROAT 1.4% SPRAY 49348-0991-36 0.01277 ML 2024-09-18
SM SORE THROAT 1.4% SPRAY 49348-0991-36 0.01279 ML 2024-08-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Sore Throat Remedies

Executive Summary

The market for sore throat remedies, including lozenges, sprays, and other treatments, is poised for significant growth driven by increasing cases of respiratory infections, changing lifestyles, and a rising demand for effective and convenient treatments.

Global Market Outlook

The global market for cold, cough, and sore throat remedies is expected to expand substantially over the next decade. Here are some key insights:

  • Market Size and Growth: The cold, cough, and sore throat remedies market was valued at USD 41.22 billion in 2023 and is projected to reach USD 56.17 billion by 2032, growing at a CAGR of 3.5% during the forecast period of 2024-2032[1].
  • Regional Dominance: The Asia Pacific region dominates the market and is expected to maintain its supremacy due to rising consumer disposable income, increased consumer awareness, and a preference for natural treatments[1].

Sore Throat Lozenges Market

Sore throat lozenges are a significant segment within the broader market for sore throat remedies.

  • Market Value and Growth: The global sore throat lozenges market was valued at approximately USD 4.4 billion in 2024 and is expected to reach USD 7.5 billion by 2034, growing at a CAGR of 5.6% during the forecast period[5].
  • Product Segmentation: The market is segmented into hard candy lozenges, soft lozenges, and compressed lozenges. It also includes OTC and prescription types, distributed through various channels such as hospital pharmacies, retail pharmacies, drug stores, and online pharmacies[2][5].
  • Key Regions: North America, particularly the United States, and countries like China, Japan, Germany, and India are driving the demand for sore throat lozenges. The U.S. accounts for about 92.7% of the North American sore throat lozenges market[5].

Throat Sprays Market

Throat sprays are another important category in the sore throat remedies market.

  • Market Size and Growth: The throat sprays market was valued at USD 511.2 million in 2024 and is expected to reach USD 840.61 million by 2037, growing at a CAGR of more than 3.9% during the forecast period[4].
  • Segmentation: The market is segmented into anti-inflammatory, anesthetics, pain relief, anti-bacterial, and natural extract throat sprays. Anesthetics throat sprays are anticipated to grow significantly due to their fast relief actions against seasonal infections[4].

Pharyngitis Market

Pharyngitis, which includes sore throat conditions, also contributes to the overall market dynamics.

  • Market Value and Growth: The pharyngitis market is expected to grow from USD 1.45 billion in 2024 to USD 2.08 billion by 2034, at a CAGR of 3.7% during the forecast period. The demand for beta-lactams is projected to increase significantly, reaching USD 776.3 million by 2034[3].

Distribution Channels

The distribution of sore throat remedies is crucial for their accessibility and market growth.

  • Retail Pharmacies and Drug Stores: These channels are expected to see significant growth, with demand for pharyngitis treatment products through these channels projected to increase at a CAGR of 3.9% and reach a value of USD 1.22 billion by 2034[3].
  • E-Commerce/Online Pharmacies: Online channels are also gaining traction, offering convenience and contributing to the overall market growth[1][2].

Key Drivers and Restraints

Several factors drive and restrain the market for sore throat remedies:

  • Key Drivers: Rising rates of respiratory infections, affordable prices, widespread drug availability, and patient demand for quick and effective treatments are key drivers. Additionally, increasing consumer expenditure on healthcare products and the preference for natural treatments contribute to market growth[1][5].
  • Key Restraints: Concerns about side effects and safety, generic competition, and seasonal demand fluctuations are significant restraints[1].

Competitive Landscape

The market for sore throat remedies is competitive, with several key players:

  • Prominent Players: Companies such as Reckitt Benckiser, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, AstraZeneca, iNova Pharmaceuticals, Procter & Gamble, Ricola AG, and Mondelēz International are major players in the market[1][5].

Regional Analysis

The market is analyzed across various regions, each with its unique dynamics:

  • Asia Pacific: This region dominates the market due to rising consumer disposable income and a preference for natural treatments[1].
  • North America: This region, particularly the U.S., is a significant market for sore throat lozenges and sprays, driven by a large population and high healthcare expenditure[5][4].
  • Europe: Countries like Germany are expected to grow at a CAGR of 5.2% through 2034, driven by the presence of top pharmaceutical manufacturers[5].

Price Projections

Given the growth rates and market dynamics, here are some price projections:

  • Sore Throat Lozenges: The market is expected to expand from USD 4.4 billion in 2024 to USD 7.5 billion by 2034, indicating a significant increase in prices driven by demand and innovation[5].
  • Throat Sprays: The market is projected to grow from USD 511.2 million in 2024 to USD 840.61 million by 2037, reflecting a steady increase in prices due to growing demand and advancements in products[4].

Key Takeaways

  • The global market for sore throat remedies is expected to grow significantly, driven by rising respiratory infections and consumer demand.
  • Sore throat lozenges and throat sprays are key segments, with lozenges projected to reach USD 7.5 billion by 2034 and throat sprays expected to reach USD 840.61 million by 2037.
  • Asia Pacific and North America are dominant regions, with Europe also showing promising growth.
  • Distribution through retail pharmacies, drug stores, and online channels is crucial for market growth.
  • Key players are investing in innovation and expanding their product portfolios to capture market share.

Frequently Asked Questions (FAQs)

Q: What is the projected growth rate of the sore throat lozenges market? A: The sore throat lozenges market is expected to grow at a CAGR of 5.6% from 2024 to 2034[5].

Q: Which region dominates the cold, cough, and sore throat remedies market? A: The Asia Pacific region dominates the market and is expected to maintain its supremacy[1].

Q: What are the key drivers of the sore throat remedies market? A: Rising rates of respiratory infections, affordable prices, widespread drug availability, and patient demand for quick and effective treatments are key drivers[1].

Q: Which companies are major players in the sore throat remedies market? A: Companies such as Reckitt Benckiser, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, AstraZeneca, iNova Pharmaceuticals, Procter & Gamble, Ricola AG, and Mondelēz International are major players[1][5].

Q: How is the distribution of sore throat remedies impacting the market? A: Distribution through retail pharmacies, drug stores, and online channels is crucial for market growth, with these channels expected to see significant increases in demand[1][3].

Cited Sources:

  1. SNS Insider: Cold, Cough, & Sore Throat Remedies Market Size Report 2032.
  2. GlobeNewswire: Sore Throat Lozenges Market Forecast a Steady Growth at 5.6% CAGR, Projected to Hit US$ 7.5 Billion by 2034.
  3. Fact.MR: Pharyngitis Market Size & Industry Share | Statistics By 2034.
  4. ResearchNester: Throat Sprays Market Analysis - Growth Outlook 2037.
  5. Future Market Insights: Sore Throat Lozenges Market Size & Forecast to 2034.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.